10. Amato M., Zipoli V. Clinical management of cognitive impairment in multiple sclerosis: a review of current evidence // Int. MS J.
– 2003.
– Vol. 10.
– P. 73–83.

11. Bakshi R., Shaikh Z.A., Miletich R.S. et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability // Mult. Scler.
– 2000.
– Vol. 6(3).
– P. 181–185.

12. Barak Y., Achiron A. Effect of interferon beta-lb on cognitive functions in multiple sclerosis // Eur. Neurol.
– 2002.
– Vol. 47.
– P. 11–14.

13. Beatty W.W., Goodkin D.E., Monson N. et al. Cognitive disturbances in patients with relapsing remitting multiple sclerosis // Ibid.
– 1989.
– Vol. 46.
– № 10.
– P. 1113–1119.

14. Blinkenberg M., Rune K., Jensen С. V. et al. Critical cerebral metabolism correlates with MR1 lesion load and cognitive dysfunction in multiple sclerosis // Neurology.
– 2000.
– Vol. 54.
– P. 558–564.

15. Boudineau M., Deloire M., Bonnet M. et al. Is cognitive complaint a marker of cognitive impairment in early relapsing-remitting multiple sclerosis? // Multiple Sclerosis.
– 2003.
– P. 133.

16. Camp S., Stevenson V., Thompson A. et al. Cognitive function in primary progressive and transitional progressive multiple sclerosis. A controlled study with MRI correlates // Brain.- 1999.-Vol. 122.- P. 1341–1348.

17. Feinstein A. The clinical neuropsychiatry of multiple sclerosis.
– Cambridge University Press, 2000.
– 204 p.

18. Fisher J., Priore R., Jacobs L. et al. Neuropsychological effects of interferon beta-la in relapsing multiple sclerosis // Ann. Neurol.
– 2000.
– Vol. 48.
– P. 885–892.

19. Fisk J.D., Pontefract A., Ritvo P.G., Archibald C.J., Murray T.J. The impact of fatigue on patients with multiple sclerosis // Can. J. Neurol Sci.
– 1994.
– Vol. 21.
– P, 9-14.

20. Flechter S., Pollak L, Vardi J., Rabey J. The event related potential P-300 and Wisconsin card sorting test in multiple sclerosis patients treated with interferon beta-lb: an open label, prospective, one year study // Presented at Congress: 2003: 13th ENS, Istanbul.

21. Geiselmann V. Metachromatic leukodystrophy: recent research developments // J. Child Neurol.
– 2003.
– Vol. 18.
– P. 591–594.

22. Geisler M., Sliwinski M, Coyle P. et al. The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis // Arch. Neurol.
– 1996.
– Vol. 53 — P. 185–188.

23. Glanz B., Holland C., Amunwa E. et al. Prevalens and pattern of cognitive impairment in early multiple sclerosis // Multiple Sclerosis.
– 2003.
– P. 132.

24. Johnson S., Guldrun L., DeLuca J., Korn L., Natelson B. The effects of fatigue on neuropsychological performance in patients with chronic fatigue syndrome, MS, and depression //Appl. Neuropsychol.
– 1997.
– Vol. 4.
– P. 145–153.

25. Kesselring J., Klement U. Cognitive and affective disturbances in multiple sclerosis // J. Neurol.
– 2001.
– Vol. 248.
– P. 180–183.

26. Koeppen A.H., Robitaille Y. Pelizaeus-Merzbacher disease / J. Neuropathol. Exp. Neurol.
– 2002.
– Vol. 61.
– P. 747–759.

27. Krupp L.B. Fatigue in multiple sclerosis: A Guide to diagnosis and management // Demos Medical Publishing, 2004.

28. Kumar A J., Rosenbaum A.E., Naidu S. et al. Adrenoleukodystrophy: correlation MR imaging with CT // Radiology.
– 1987.
– Vol. 165.
– P. 497–504.

29. Mendez M.F., Cummings J.L. Miscellaneous Dementia Syndromes / In: «Dementia: A clinical approach».
– 3rd ed.
– Philad.: Butterworth Heinemann, 2003.
– P. 527–521.

30. Minden S.L., Schiffer R.B. Affective disorders in multiple sclerosis. Review and recommendations for clinical research //Arch. Neurol.
– 1990.
– Vol. 47.
– P. 98–104.

31. Pepper C. M., Krupp L.B., Friedberg F. et al. A comparison of neuropsychiatry characteristics in chronic fatigue syndrome, multiple sclerosis and major depression // J. Neuropsychiatry Clin. Neurosci.
– 1993.
– Vol. 5.
– P. 200–205.

32. Rao S.M., Leo G.J., Bernadin L. et al. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns and prediction // Neurology.
– 1991.
– Vol. 41.
– P. 685–691.